Vor Biopharma Inc [VOR] Investment Appeal on the Rise

Anna Perez

In a filing, Vor Biopharma Inc revealed its Director RA CAPITAL MANAGEMENT, L.P. unloaded Company’s shares for reported $6.34 million on Oct 29 ’25. In the deal valued at $25.22 per share,251,518 shares were sold. As a result of this transaction, RA CAPITAL MANAGEMENT, L.P. now holds 804,231 shares worth roughly $8.62 million.

Then, RA CAPITAL MANAGEMENT, L.P. sold 124,311 shares, generating $3,408,230 in total proceeds. Upon selling the shares at $27.42, the Director now owns 1,055,749 shares.

Before that, RA CAPITAL MANAGEMENT, L.P. sold 24,579 shares. Vor Biopharma Inc shares valued at $617,424 were divested by the Director at a price of $25.12 per share. As a result of the transaction, RA CAPITAL MANAGEMENT, L.P. now holds 779,652 shares, worth roughly $8.36 million.

JP Morgan initiated its Vor Biopharma Inc [VOR] rating to an Overweight in a research note published on December 09, 2025; the price target was $43. Robert W. Baird also remained covering VOR and has increased its forecast on October 15, 2025 with a “an Outperform” recommendation from previously “Neutral” rating. Stifel revised its rating on September 24, 2025. It rated VOR as “a Buy” which previously was an “a Hold”.

Price Performance Review of VOR

On Tuesday, Vor Biopharma Inc [NASDAQ:VOR] saw its stock jump 28.23% to $10.72. Over the last five days, the stock has gained 42.36%. Vor Biopharma Inc shares have fallen nearly -36.57% since the year began. Nevertheless, the stocks have fallen -51.71% over the past one year. While a 52-week high of $65.80 was reached on 07/08/25, a 52-week low of $2.62 was recorded on 05/09/25.

Levels Of Support And Resistance For VOR Stock

The 24-hour chart illustrates a support level at 8.84, which if violated will result in even more drops to 6.96. On the upside, there is a resistance level at 12.71. A further resistance level may holdings at 14.70.

How much short interest is there in Vor Biopharma Inc?

A steep rise in short interest was recorded in Vor Biopharma Inc stocks on 2025-11-14, dropping by -0.94 million shares to a total of 0.29 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 1.24 million shares. There was a decline of -319.85%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.